United States · FDA National Drug Code directory
Allegra-D Allergy and Congestion
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 41167-4320_de126d31-d1bb-490f-bf3f-fd9faf4f20ab
- Product NDC
- 41167-4320
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Composition / generic term
- fexofenadine hydrochloride and pseudoephedrine hydrochloride
- Labeler
- Chattem, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20110303
- Source listing expiry
- 20271231
Source-listed ingredients
- FEXOFENADINE HYDROCHLORIDE — 180 mg/1
- PSEUDOEPHEDRINE HYDROCHLORIDE — 240 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 2 BLISTER PACK in 1 CARTON (41167-4320-5) / 5 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK · 41167-4320-5
- 3 BLISTER PACK in 1 CARTON (41167-4320-7) / 5 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK · 41167-4320-7
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →